LEQEMBI® Infusion Therapy

Download Referral Form

About LEQEMBI® Infusion Therapy

LEQEMBI® is an FDA approved injectable treatment for Alzheimer';s disease. It worked by reducing amyloid plaques in the brain. It is one of the first medications designed to actually slow down he progression of Alzheimer's disease rather than just treating the symptoms. LEQEMBI® is a monoclonal antibody that binds to beta-amylpoid before plaque formation, helping to prevent the accumulation of amyloid plaques in the brain.

Condition treated by this therapy

LEQEMBI® is approved for early Alzheimer's disease with mild cognitive impairment (MCI) or mild dementia stage of the disease. This medication is specifically for people with confirmed amyloid pathology in the brain.

LEQEMBI® Price

The out-of-pocket LEQEMBI®price will vary depending on your insurance coverage. If you have questions about your coverage, contact your insurance provider.

No patient should go without necessary treatment due to financial limitations. If you have questions about financial assistance opportunities, contact a member of our Violet Health team.

What to Expect During LEQEMBI® Infusion Therapy

LEQEMBI® is administered as an intravenous infusion, typically infused over an hour once every 2 weeks.

Pre-treatment testing includes:

MRI brain sans (LEQEMBI® requires four brain MRI scans prior to treatment)
Testing for the APOE4 gene, which could increase your risk of side effects
Medication review, especially blood thinners

Expect to get regular MRI scans to monitor for any changes in your brain. Treatment may slow disease progression by approximately 27% compared to no treatment.

LEQEMBI® Side Effects

LEQEMBI® reactions can include symptoms of Amyloid-Related Imagine Abnormalities (ARIA). About 22% of patients taking LEQEMBI® experienced ARIA in clinical trials. Other symptoms of LEQEMBI® include infusion-related reactions such as:

Flu-like symptoms
Chills
Fever
Nausea
Face or mouth swelling

Watch out for symptoms of ARIA which can manifest as brain swelling and bleeding, a common problem to all plaque-targeting drugs. Risk is higher for people with APOE4 gene. Patients should not take LEQEMBI® if they have bleeding problems. Not recommended for those on blood thinners other than Aspirin.

LEQEMBI® Infusion Therapy at Violet Health

Your comfort during LEQEMBI® infusion therapy at Violet Health is our priority. Our LEQEMBI® patients enjoy walk-up parking, complimentary entertainment and snacks, and a team of highly trained providers during each treatment. Plus, Violet Health’s evening and weekend hours and convenient city and rural locations make it easier to schedule your appointments.

Violet Health Infusion Centers provides infusion therapy for patients with rare, chronic, or complex conditions in a comfortable, patient-centered atmosphere.

Find Infusion Center Near You!

Helpful Resources

Patient Forms

Before you attend your first appointment at Violet Health, please make sure to review the documents below. Please contact us if you have any questions!